Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2016
September 14 - 17, 2016; London, United Kingdom
September 14 - 17, 2016London, United Kingdom
ECTRIMSMany Patients With MS Consider Physician-Assisted DeathIn a survey of almost 7000 patients with MS, more than half said they'd consider physician-assisted death in one of five hypothetical situations, such as unbearable pain or being a financial burden.
Medscape Medical News, October 12, 2016
ECTRIMSBlood Test for Multiple Sclerosis?The IQIsolate system identifies diagnostic gene expression patterns consistent with multiple sclerosis in peripheral whole blood samples with 90% accuracy, report investigators.
Medscape Medical News, October 7, 2016
ECTRIMSVitamin D Deficiency, Smoking May Increase Disability in CISPatients with clinically isolated syndrome and low vitamin D or high cotinine levels had twice the risk for disease severity as nonsmokers or those with normal vitamin D, a new study shows.
'Ground-Breaking' Ocrelizumab Data Dominate ECTRIMSThe results of three new phase 3 studies with the new anti-B cell humanized antibody for multiple sclerosis were the major
talking point among delegates attending the recent ECTRIMS meeting in Barcelona.
Medscape Medical News, Oct 16, 2015
Anti-LINGO Agent Promotes Remyelination in Optic Neuritis New research shows an investigational monoclonal antibody may have a positive effect not only on the affected eye but also
the unaffected eye in patients with acute optic neuritis.
Mark Freedman, MD Director, Multiple Sclerosis Research Unit, The Ottawa Hospital, Ontario, Canada Presentation: Immunoablation and haematopoietic stem cell transplantation completely aborts inflammation in aggressive relapsing forms of
MS Date: September 15, 2016